| Heading: |
Caribbean: Health Services |
| Question ID: |
1784405 |
| UIN: |
37989 |
| House: |
Commons |
| Date tabled: |
2025-03-13 |
| Asking Member ID: |
1447 |
| Asking Member display name: |
Andrew Rosindell
|
| Asking Member handle: |
AndrewRosindell
|
| Asking Member Twitter reference: |
@AndrewRosindell
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of EU investment in local pharmaceutical production in the Caribbean on UK-Caribbean healthcare partnerships. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-21 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Government has not made any assessment of the potential impact of this investment. The United Kingdom remains committed to working with Caribbean partners to strengthen healthcare systems, and to supporting healthcare development and collaboration in ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |